Status:

COMPLETED

Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)

Lead Sponsor:

AO Clinical Investigation and Publishing Documentation

Conditions:

Pertrochanteric Fractures of Femur

Intertrochanteric Fractures of the Femur

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this project is the prospective data collection of a new device used for trochanteric fractures of the femur. It should be answered how the newly developed implant called Trochanteric Fixat...

Detailed Description

In comparison to previous implants, the TFNA has been improved substantially. Therefore the purpose of this focused registry is to investigate how the newly developed implant called Trochanteric Fixat...

Eligibility Criteria

Inclusion

  • Age 18 years and older
  • Pertrochanteric femoral fracture (31-A1 and 31-A2), intertrochanteric fracture (31-A3), fracture of the trochanteric area (31-A1/A2/A3) with diaphyseal extension or combined fracture of the trochanteric area and the femoral shaft (32-A/B/C) treated with the TFNA system according to the technique guide
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the registry according to the registry plan (RP)
  • Signed and dated IRB/EC-approved written informed consent or assent from a family member

Exclusion

  • Additional acute fracture
  • Any not medically managed severe systemic disease
  • Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the registry period
  • Prisoner
  • Participation in any other medical device or medicinal product registry within the previous month that could influence the results of the present registry
  • Intraoperative decision to use implants other than the devices under investigation

Key Trial Info

Start Date :

March 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2017

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT02305121

Start Date

March 1 2015

End Date

November 1 2017

Last Update

August 12 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Medical University Innsbruck

Innsbruck, Austria, 6020

2

Kantonsspital Baselland

Liestal, Switzerland, 4410